Clinical and pathological characteristics related to parametrial involvement in clinical early-stage cervical cancer by Boyraz, Gokhan et al.
417
ORIGINAL PAPER /  GYNECOLOGY
Ginekologia Polska
2016, vol. 87, no. 6, 417–421
Copyright © 2016 Via Medica
ISSN 0017–0011
DOI: 10.5603/GP.2016.0018
Clinical and pathological characteristics related  
to parametrial involvement in clinical early-stage 
cervical cancer
Gokhan Boyraz, Derman Basaran, Mehmet C. Salman, Nejat Ozgul, Kunter Yuce
Department of Obstetrics and Gynecology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
ABSTRACT
Objectives: Since parametrial involvement is believed to be a crucial factor in the management of cervical cancer, our study 
was designed to investigate the clinical and pathological features which predicted parametrial involvement in patients 
with clinical early-stage cervical cancer. 
Material and methods: The study included patients with clinical early-stage cervical cancer who underwent radical hys-
terectomy with pelvic and para-aortic lymphadenectomy between December 2001 and August 2014, at the Hacettepe 
University Hospital. The clinical and pathological characteristics of the affected patients were evaluated, including age, 
histologic subtype, tumor size, depth of cervical stromal invasion, lympho-vascular space invasion (LVSI), and lymph node 
metastasis. Univariate and multivariate analyses were performed to reveal factors associated with parametrial involvement.
Results: The study group consisted of 126 patients (mean age: 52.7 years; range: 29–83), including 101 (80.2%) with 
squamous, 19 (15.1%) with adenocarcinoma, and 6 (4.8%) with adenosquamous histological subtype of cervical cancer. 
Parametrial involvement and lymph node metastasis were detected in 41 (32.5%) and 46 (36.5%) women, respectively. 
Univariate analysis showed that deep cervical stromal invasion, LVSI, tumor size > 2 cm and lymph node metastasis were 
associated with parametrial involvement. Multivariate logistic regression analysis identified the independent risk factors 
associated with parametrial involvement as LVSI (OR 8.93, 95% CI 1.1–73.5, p = 0.042) and lymph node metastasis (OR 8.8, 
95% CI 1.5–9.3, p = 0.004). 
Conclusions: LVSI, deep cervical stromal invasion, lymph node metastasis and tumor size are significantly associated with 
parametrial involvement in patients with clinical early-stage cervical cancer.
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INTRODUCTION
Cervical cancer is the third most frequent common gy-
necologic cancer, preceded only by endometrial and ovar-
ian cancer, and a common cause of gynecologic cancer-re-
lated death despite the availability of effective screening 
tools [1]. In contrast to other gynecological cancers, staging 
of cervical cancer is based on clinical examination accord-
ing to the International Federation of Gynecology and Ob-
stetrics (FIGO) criteria [2]. Radical hysterectomy and pelvic 
lymphadenectomy remains the standard treatment option 
for most patients with clinical early-stage cervical cancer. 
The advantages of surgical treatment include removal of 
the primary tumor, shorter treatment time, the possibility 
to preserve ovarian and sexual function, and to determine 
the need for adjuvant therapy by histologic examination [3]. 
In contrast to simple hysterectomy, radical hysterectomy 
involves removal of the parametrial tissue and is associ-
ated with adverse impact on the quality of patient life [4]. 
Visceral injuries, bleeding, infection and febrile morbidity, 
fistula formation, sexual dysfunction, bladder and bowel 
dysfunction are the most common complications of radical 
hysterectomy and some of these problems may be irrevers-
ible [5]. Direct extension and lymphatic dissemination are 
the most common routes of spread in cervical cancer. There-
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fore, parametrium and lymph nodes are typical metastasis 
locations and removal of these tissues is vial in cervical 
cancer treatment [6]. However, most of the complications 
related to radical hysterectomy are also associated with 
parametrial resection due to autonomic nerve damage [7]. 
In selected patients with early stage cervical cancer, less radi-
cal surgical procedures without parametrial resection (e.g. 
simple hysterectomy or conization) may be associated with 
fewer surgical complications. The assessment of parametrial 
involvement must be done before omission of parametrial 
resection in candidates for less radical surgery [8]. 
OBJECTIVES
Since parametrial involvement is believed to be a crucial 
factor in the management of cervical cancer, our study was 
designed to investigate the clinical and pathological fea-
tures which predicted parametrial involvement in patients 
with clinical early-stage cervical cancer.
MATERIAL AND METHODS
The study included patients with clinical early-stage 
cervical cancer who underwent radical hysterectomy and 
pelvic and para-aortic lymphadenectomy between De-
cember 2001 and August 2014 at the Hacettepe University 
Hospital. Piver-Rutledge type III radical hysterectomy was 
performed, with the removal of uterus, cervix, upper third 
of the vagina and parametrial resection until the pelvic 
sidewall. Lymphadenectomy consisted of systematic pelvic 
and para-aortic lymph node dissection up to the level of 
inferior mesenteric artery. The patients were staged by 
clinical examination according to the 2009 FIGO criteria. 
A total of 126 consecutive women were analyzed retro-
spectively. The clinical and pathological characteristics 
of the patients were evaluated, including patient age, 
histologic subtype, tumor size, depth of cervical stromal 
invasion, lympho-vascular space invasion (LVSI), and lymph 
node metastasis. Statistical analyses were performed us-
ing SPSS software version 17.0 statistical package. Cross 
tabulations were analyzed using χ2 or Fisher’s exact test. 
Non-parametric continuous variables were analyzed us-
ing the Mann-Whitney U test. The p-value of < 0.05 was 
considered as statistically significant.
As this study represents a retrospective chart review, 
permission of the Local Ethics Committee was not sought. 
However, all patients signed an informed consent which 
allowed our institution to use their clinical data.
RESULTS
The clinical and pathological characteristics of the cases 
are summarized in Table 1. The study group consisted of 
126 patients (mean age: 52.7 years; range: 29–83), including 
69 (54.8%) postmenopausal and 57 (45.2%) premenopausal 
women. Of the 126 patients, 101 (80.2%) had squamous, 
19 (15.1%) had adenocarcinoma, and 6 (4.8%) had adenos-
quamous histological subtype of cervical cancer. Parame-
trial involvement was detected in 41 (32.5%) subjects. Of 
the 41 cases with parametrial involvement, 22 (17.5%) had 
microscopic and 19 (15.1%) had macroscopic involvement, 
based on the pathology report. While 39 cases had direct 
parametrial spread, lymphatic parametrial spread was de-
tected in 5 cases. 
Of the factors analyzed for correlation with parametrial 
involvement in clinical early-stage cervical cancer, tumor 
size, lympho-vascular space invasion, deep cervical invasion, 
and lymph node metastasis were found to be significant 
predictors of parametrial involvement (Table 2). While only 
1 of the patients with ≤ 2 cm tumor size had parametrial 
involvement, 40 (37.73%) of the 106 patients with > 2 cm 
tumor size had parametrial involvement.
Deep cervical stromal invasion (≥ 50% of full thickness) 
was detected in 107 (84.9%) subjects. While parametrial 
involvement was detected in 41 (38.31%) of the 107 patients 
with deep cervical stromal invasion, none of the patients 
with superficial cervical stromal invasion had parametrial 
involvement (p = 0.001).
LVSI was detected in 96 (76.2%) patients and the remain-
ing 30 patients did not have LVSI. Of the 30 patients without 
Table 1. Clinical and pathological characteristics of the study 
population 
Variable Patients (n = 126)
Mean age (years) 52.7 (ranging 29–83) 
Histology
Squamous carcinoma 
Adenocarcinoma 
Adenosquamous carcinoma 
 
101 (80.2%)
19 (15.1%)
6 (4.8%)
Tumor size [cm] 
2 or less 
More than 2 
 
20 (15.9%)
106 (84.1%)
Depth of cervical stromal invasion
< 50% of full thickness
≥ 50% of full thickness 
 
19 (15.1%)
107 (84.9%)
Lymphovascular space invasion 
Yes 
No 
 
96 (76.2%)
30 (23.8%)
Lymph node metastasis 
Yes 
Only Pelvic 
Only Para-aortic 
Pelvic + Para-aortic 
No 
 
46 (36.5%)
36 (28.5%)
2 (1.5%)
8 (6.34%)
80 (63.5%)
Parametrial involvement
Yes 
No 
 
41 (32.53%)
85 (67.47%)
Surgical margin 
Positive 
Negative 
 
16 (12.7%)
110 (87.3%)
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LVSI, only 1 had parametrial involvement. On the other hand, 
of the 96 patients with LVSI, 40 (41.66%) had parametrial 
involvement (p < 0.001).
No statistically significant difference between age and 
parametrial involvement was identified (p = 0.772). Ad-
ditionally, there was no statistically significant difference 
between histologic subtype and parametrial involvement 
(p = 0.362). Multivariate logistic regression analysis was 
performed to identify factors related to parametrial involve-
ment. The examined factors included age, histology, tumor 
size, depth of cervical stromal invasion, lympho-vascular 
space invasion, and lymph node metastasis. LVSI (OR 8.93, 
95% CI 1.1–73.5, p = 0.042) and lymph node metastasis (OR 
8.8, 95% CI 1.5–9.3, p = 0.004) were the only independent 
predictors associated with parametrial involvement.
DISCUSSION 
After the diagnosis of cervical cancer, all patients should 
undergo a clinical staging evaluation to determine the treat-
ment approach. In this way, patients with cervical cancer 
can be classified as early (stage 1–2A) or locally advanced 
stage (stage 2B–4A) disease. Whilst clinical early-stage 
cervical cancer can be treated by radical hysterectomy or 
concomitant chemoradiation, patients with clinical locally 
advanced-stage cervical cancer are treated with primary 
chemoradiation [9]. The most important factor in the treat-
ment of cervical cancer is to avoid using multimodality 
treatment which consists of chemoradiation and surgery.
Radical surgery for cervical cancer is associated with sig-
nificant complications including fistula formation, bladder 
and sexual dysfunction [10]. Therefore, patients with low-risk 
characteristics for parametrial involvement could be treated 
with less radical approach such as simple hysterectomy or 
cervical conization. On the other hand, oncological safety 
of the less radical procedures have not yet been proven and 
clinicians should select patients with low-risk features with 
meticulous effort. 
More recent studies estimated the rate of parametrial 
involvement in patients with clinical early-stage cervical can-
cer at 4–11% [11, 12]. However, the parametrial involvement 
was detected in 41 (32.5%) patients in our study. Wright 
et al., reported an association between tumor histology 
and parametrial involvement, but such association was not 
present in our patient cohort [13].
An association between lymph node involvement and 
parametrial involvement has been reported in the literature. 
Our findings, as well as the literature reports, suggest that 
the risk of parametrial involvement is strongly associated 
with lymphatic involvement. In our study, patients with 
lymphatic metastasis had significantly higher rates of para-
metrial involvement as compared to patients with no metas-
tasis (56.5% vs. 18.8%, p < 0.01). Frumovitz et al., found that 
15 of the 27 women with parametrial involvement also had 
positive pelvic lymph nodes, which is consistent with our 
report [7]. Kodama et al., reported that pelvic lymph node 
status is the strongest independent predictor of parametrial 
involvement [14]. Similarly, Puente et al., suggested that 
pelvic lymph node status is a good predictor of parametrial 
involvement in node-negative patients in whom less radical 
surgery could be used [15].
Table 2. Clinical and pathological characteristics related to parametrial involvement
Variable Parametrial involvement (n = 41) No parametrial involvement (n = 85) p
Mean age 55.0 51.7 0.772
Histologic type
Squamous 
Adenocarcinoma 
Adenosquamous 
 
34 (82.9%) 
4 (9.7%) 
3 (7.31%) 
 
67 (78.8%)
15 (17.6%)
3 (3.52%)
0.362 
Tumor size 
2 cm or less 
More than 2 cm 
 
1 (5%) 
40 (37.7%) 
 
19 (95%)
66 (62.3%)
0.04
Depth of cervical stromal invasion
< 50% 
≥ 50% 
 
0 (0%) 
41 (38.7%) 
 
19 (100%)
66 (61.3%)
0.001
LVSI 
Positive 
Negative 
 
40 (41.7%) 
1 (3.3%) 
 
56 (58.3%)
29 (96.7%)
< 0.001
Lymph node metastasis
Yes 
No
 
26 (56.5%) 
15 (18.8%) 
 
20 (43.5%)
65 (81.2%)
<0.001
Vaginal involvement 
Yes 
No 
 
22 (71%) 
19 (20%) 
 
9 (29%)
76 (80%)
< 0.001
LVSI — lymphovascular space invasion
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In our study, we found that LVSI, deep cervical stromal 
invasion, lymph node metastasis, and tumor size are signifi-
cant risk factors for parametrial involvement in patients with 
clinical early-stage cervical cancer. Likewise, O. Gemer et al., 
detected similar risk factors for parametrial involvement, in-
cluding tumor size, depth of invasion, LVSI, and positive lymph 
nodes [11]. These authors suggested an algorithm for patients 
with early-stage cervical cancer. According to this algorithm, 
patients with clinically early-stage cervical cancer underwent 
magnetic resonance imaging to determine tumor size. If the 
tumor was < 2 cm in diameter, large loop electro-excisional 
procedure or conization were performed to detect LVSI. They 
found that if LVSI was not documented, the rate of parametrial 
involvement was 1.8% (2/112). In our study, of the 30 cases 
with no LVSI, only 1 had parametrial involvement (3.3%). Ad-
ditionally, in patients with negative lymph nodes on laparo-
scopic lymphadectomy or sentinel node procedure, the rate 
of parametrial involvement was 0% (0/107). However, out 
of the 80 cases with no lymph node metastasis in our study, 
15 patients had parametrial involvement (18.75%).
Our findings, as well as the literature, suggest that the 
risk of parametrial involvement in patients with tumor 
size < 2 cm and no LVSI is generally low [7, 13, 16]. In our 
study, out of the 5 patients with tumor < 2 cm and no LVSI, no 
cases of parametrial involvement were noted. Likewise, Klat 
et al., reported 204 patients who underwent radical surgery 
with SLN biopsy. They found no subjects with parametrial 
involvement among women with early-stage cervical can-
cer, with tumor < 20 mm in diameter and negative sentinel 
lymph nodes [17]. Our findings are consistent with those of 
Covens et al., who also detected a correlation between tu-
mor size, LVSI, greater depth of invasion, and positive pelvic 
lymph nodes with parametrial involvement. On the other 
hand, Covens et al., and Kodama et al., found a significant 
association between older age and parametrial involve-
ment, but in our study, we observed no link between age 
and parametrial involvement [14, 18]. 
Most of the recent studies reported a low rate of parame-
trial involvement in early-stage cervical cancer patients with 
certain pathological characteristics. Hence, a more conserva-
tive approach may be considered in those women [6, 19, 20]. 
Pluta et al., evaluated 60 patients with FIGO stage IA1 and 
IB1 cervical cancer who had < 2cm tumor size and < 50% 
cervical stromal invasion. Out of the 60 patients, in 55 pa-
tients who had negative sentinel lymph nodes on frozen 
section, simple hysterectomy and pelvic lymphadenectomy 
were performed and no recurrences were detected in the 
median follow-up of 47 months. Therefore, they suggested 
that simple hysterectomy and pelvic lymphadenectomy 
may be safely performed in selected early-stage cervical 
cancer patients with certain pathologic characteristics [21].
CONCLUSIONS
LVSI, deep cervical stromal invasion, lymph node me-
tastasis, and tumor size are significantly associated with 
parametrial involvement in patients with clinical early-stage 
cervical cancer. LVSI and lymph node metastasis were the 
independent factors associated with parametrial involve-
ment in multivariate logistic regression analysis. LVSI could 
be detected with meticulous pathologic assessment in the 
preoperative period. Tumor size, deep cervical stromal in-
volvement, and lymph node status could be detected by 
magnetic resonance imaging and positron emission to-
mography/computed tomography. Thus, identification of 
patients with low risk for parametrial involvement might 
allow for a more conservative surgical approach. On the 
other hand, patients with high risk of parametrial invasion 
could be directed to primary chemoradiation and could be 
spared the morbidity of a multimodal treatment.
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